Your browser doesn't support javascript.
loading
Rheumatic disorders associated with immune checkpoint inhibitors: what about myositis? An analysis of the WHO's adverse drug reactions database.
Nguyen, Thuy; Maria, Alexandre Thibault Jacques; Ladhari, Chayma; Palassin, Pascale; Quantin, Xavier; Lesage, Candice; Taïeb, Guillaume; Ayrignac, Xavier; Rullier, Patricia; Hillaire-Buys, Dominique; Lambotte, Olivier; Guilpain, Philippe; Faillie, Jean-Luc.
Afiliação
  • Nguyen T; Department of Medical Pharmacology and Toxicology, University of Montpellier, Faculty of Medicine, Montpellier, Languedoc-Roussillon, France.
  • Maria ATJ; Department of Internal Medicine: Multi-Organic Diseases, Local Referral Center for Systemic Autoimmune Diseases, Montpellier University Hospital, University of Montpellier, Medical School, Montpellier cedex 5, France alexandremaria@hotmail.fr.
  • Ladhari C; IRMB Institute for Regenerative Medicine and Biotherapy, INSERM U1183, University of Montpellier, Montpellier, France.
  • Palassin P; Department of Medical Pharmacology and Toxicology, University of Montpellier, Faculty of Medicine, Montpellier, Languedoc-Roussillon, France.
  • Quantin X; Department of Medical Pharmacology and Toxicology, University of Montpellier, Faculty of Medicine, Montpellier, Languedoc-Roussillon, France.
  • Lesage C; Department of Medical Oncology, Montpellier Cancer Institute, University of Montpellier, Faculty of Medicine, Montpellier, Languedoc-Roussillon, France.
  • Taïeb G; Department of Dermatology, University of Montpellier, Faculty of Medicine, Montpellier, Languedoc-Roussillon, France.
  • Ayrignac X; Department of Neurology, University of Montpellier, Faculty of Medicine, Montpellier, Languedoc-Roussillon, France.
  • Rullier P; Department of Neurology, University of Montpellier, Faculty of Medicine, Montpellier, Languedoc-Roussillon, France.
  • Hillaire-Buys D; Department of Internal Medicine: Multi-Organic Diseases, Local Referral Center for Systemic Autoimmune Diseases, Montpellier University Hospital, University of Montpellier, Medical School, Montpellier cedex 5, France.
  • Lambotte O; Department of Medical Pharmacology and Toxicology, University of Montpellier, Faculty of Medicine, Montpellier, Languedoc-Roussillon, France.
  • Guilpain P; Department of Internal Medicine, Hopital Bicetre, Le Kremlin-Bicetre, France.
  • Faillie JL; Department of Internal Medicine: Multi-Organic Diseases, Local Referral Center for Systemic Autoimmune Diseases, Montpellier University Hospital, University of Montpellier, Medical School, Montpellier cedex 5, France.
Ann Rheum Dis ; 81(2): e32, 2022 02.
Article em En | MEDLINE | ID: mdl-32066555

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Inibidores de Checkpoint Imunológico / Miosite Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Inibidores de Checkpoint Imunológico / Miosite Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article